Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             31 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A multipronged approach to tackle RSV-associated disease The Lancet Respiratory Medicine,

9 10 p. 1077
artikel
2 Are changes in practice a cause of the rising burden of bronchiolitis for paediatric intensive care units? Linssen, Rosalie S

9 10 p. 1094-1096
artikel
3 Azithromycin: can its benefit be ruled out in mild COVID-19? Rodríguez-Molinero, Alejandro

9 10 p. 1079-1081
artikel
4 Azithromycin for mild-to-moderate COVID-19 Patel, Jigar

9 10 p. e99
artikel
5 Azithromycin for mild-to-moderate COVID-19 – Authors' reply Hinks, Timothy S C

9 10 p. e100-e101
artikel
6 Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial Hinks, Timothy S C

9 10 p. 1130-1140
artikel
7 Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis Busse, William W

9 10 p. 1165-1173
artikel
8 Circulation of influenza, RSV, and SARS-CoV-2: an uncertain season ahead Burki, Talha Khan

9 10 p. e103
artikel
9 Correction to Lancet Respir Med 2021; 9: 1130–40
9 10 p. e102
artikel
10 Correction to Lancet Respir Med 2021; published online Sept 1. https://doi.org/10.1016/S2213-2600(21)00331-3
9 10 p. e102
artikel
11 COVID-19 vaccines: addressing hesitancy in young people with allergies Abrams, Elissa M

9 10 p. 1090-1092
artikel
12 Do B cells rather than eosinophils drive chronic rhinosinusitis with nasal polyps? Kariyawasam, Harsha H

9 10 p. e97
artikel
13 Duration of amoxicillin-clavulanate for protracted bacterial bronchitis in children (DACS): a multi-centre, double blind, randomised controlled trial Ruffles, Tom J C

9 10 p. 1121-1129
artikel
14 GINA 2021: the missing pieces in the childhood asthma puzzle Santamaria, Francesca

9 10 p. e98
artikel
15 Increasing utility of FeNO as a biomarker of type-2 inflammation in severe asthma Chung, Kian Fan

9 10 p. 1083-1084
artikel
16 Interstitial lung diseases: quo vadis? Kreuter, Michael

9 10 p. 1084-1087
artikel
17 Managing chronic wet cough in children: another piece of the puzzle Gilchrist, Francis J

9 10 p. 1078-1079
artikel
18 Mepolizumab for chronic rhinosinusitis with nasal polyps Brusselle, Guy G

9 10 p. 1081-1082
artikel
19 Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial Han, Joseph K

9 10 p. 1141-1153
artikel
20 Mildly elevated pulmonary artery systolic pressure on echocardiography: bridging the gap in current guidelines Jankowich, Matthew

9 10 p. 1185-1191
artikel
21 Moving beyond usual interstitial pneumonia to define progressive fibrotic interstitial lung disease Podolanczuk, Anna J

9 10 p. 1087-1089
artikel
22 Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study Lu, Shun

9 10 p. 1154-1164
artikel
23 Optimising clinical trials in acute myocardial infarction complicated by cardiogenic shock: a statement from the 2020 Critical Care Clinical Trialists Workshop Arrigo, Mattia

9 10 p. 1192-1202
artikel
24 Pathological disease in the lung periphery after acute COVID-19 Siddiqui, Salman

9 10 p. 1089-1090
artikel
25 Perplexing mortality data from triple therapy trials in COPD – Author's reply Martinez, Fernando J

9 10 p. e96
artikel
26 Respiratory syncytial virus and asthma: untying the Gordian knot Hartert, Tina V

9 10 p. 1092-1094
artikel
27 Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial Ruckwardt, Tracy J

9 10 p. 1111-1120
artikel
28 Story from a survivor of tuberculosis Linton, Emma

9 10 p. 1098-1100
artikel
29 The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study McDowell, P Jane

9 10 p. 1174-1184
artikel
30 Tobacco industry capitalises on the COVID-19 pandemic Burki, Talha Khan

9 10 p. 1097-1098
artikel
31 Variations in end-of-life practices in intensive care units worldwide (Ethicus-2): a prospective observational study Avidan, Alexander

9 10 p. 1101-1110
artikel
                             31 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland